STAT

FEBRUARY 1, 2023

” But based on a final regulation published Monday, Medicare is going against that public interest by giving a free pass to Medicare Advantage plans for any erroneous codes they submitted between 2011 and 2017. The amount of taxpayer money that insurers will get to keep because of that decision: $2 billion.

280

280

STAT

MAY 16, 2023

The analysis showed improvement was made in narrowing long-standing health gaps between Black and white Americans between 1999 and 2011, but progress stalled through 2019. In the last two decades, Black Americans have suffered 1.63

280

280

STAT

APRIL 30, 2024

Founded in 2011, Akili Interactive made waves in 2020 when it received Food and Drug Administration clearance for EndeavorRx , its treatment for young people with ADHD. Earlier this year, Better Therapeutics, developer of an FDA-cleared app for the treatment of type 2 diabetes shut down operations.

Diabetes 306

Diabetes 306

STAT

OCTOBER 19, 2022

In 2011, the same year that Makena received accelerated approval from the FDA, I was a member of a similar FDA advisory committee hearing in which we considered withdrawing the breast cancer indication for the drug Avastin. We’ve been here before.

254

254

STAT

JANUARY 9, 2023

Wall Street had been watching sales figures closely, for fear that competition from biosimilars — a form of generic — and new medicines from rival drugmakers could cut into the sales that have fueled Regeneron’s growth since Eylea was approved in 2011. Continue to STAT+ to read the full story…

Biosimilars 254

Biosimilars 254

STAT

NOVEMBER 27, 2023

Amid concerns over the use of medically important antibiotics given to food-producing livestock, sales of veterinary medicines across Europe dropped by 53% between 2011 and 2022, which regulators reported is the biggest drop ever recorded and a sign that campaigns to reduce usage are working.

286

286

STAT

NOVEMBER 18, 2022

Amid ongoing concerns over the use of medically important antibiotics given to food-producing livestock and farmed fish, sales of veterinary medicines across Europe dropped by nearly half between 2011 and 2021, which regulators reported is the biggest drop ever recorded and a sign that campaigns to reduce use are working.

246

246

STAT

FEBRUARY 21, 2024

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Diabetes 296

Diabetes 296

STAT

APRIL 18, 2023

A February 2023 report from Chartis , a health care consulting firm, found that 217 labor and delivery units have closed across the nation since 2011. The trend of rural hospitals shuttering perinatal services is not new. When these facilities close, the care of both pregnant people and their newborns must occur elsewhere.

Hospitals 246

Hospitals 246

STAT

AUGUST 3, 2023

In 2011, President Obama signed the National Alzheimer’s Project Act into law, establishing a national goal of preventing and effectively treating the disease by 2025. Medicare’s policies are creating obstacles that make it more difficult for patients who are highly likely to benefit to obtain access to diagnosis and treatment.

246

246

STAT

JUNE 25, 2024

The justices threw out a lower court ruling that revived a lawsuit brought by the military personnel and civilians who said they were harmed between 2005 and 2011 in the Iraq war. The justices asked the lower court to reconsider the case.

273

273

pharmaphorum

MAY 30, 2024

The US Congress has passed the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s enacted in 2011

119

119

STAT

OCTOBER 23, 2024

regulators in 2011. Court of Appeals for the Federal Circuit rejected Regeneron’s request to block the launch during its appeal of a related decision for Amgen in a patent case in West Virginia. Eylea can treat eye diseases like macular degeneration, macular edema, and retinopathy, and was first approved by U.S. billion in U.S.

Compounding 260

Compounding Compounding Pharmacies Biosimilars Documentation 260

ALiEM - Pharm Pearls

JANUARY 22, 2024

2011 Oct 18;183(15):E1152. Epub 2011 Sep 12. Curr Infect Dis Rep. 2009 Jan;11(1):66-72. doi: 10.1007/s11908-009-0010-x. PMID: 19094827. Shiao CC, Lin SY. Eschar: a clue to scrub typhus. doi: 10.1503/cmaj.101929. PMID: 21911554; PMCID: PMC3193135.

Documentation 161

Documentation Hospitals 161

Med Ed 101

JUNE 16, 2024

I’ve maintained my BCGP certification (formerly CGP) since 2011. I’m happy to report this was the third time I’ve taken and passed the exam (and recertification exam). I can safely say that I feel […] The post BCGP Exam Study Tips – I Passed! Again) appeared first on Med Ed 101.

105

105

ALiEM - Pharm Pearls

AUGUST 28, 2023

2011 Dec;145(6):935-9. Epub 2011 Jul 13. Imaging and specialist referral should be considered in cases concerning for tumor, abscess, or treatment failure. References Huoh KC, Eisele DW. Etiologic factors in sialolithiasis. Otolaryngol Head Neck Surg. doi: 10.1177/0194599811415489. PMID: 21753035.

Hospitals 130

Hospitals 130

ALiEM - Pharm Pearls

OCTOBER 21, 2024

2011 Jan;13(1):21-4. Treat this condition with anti-pseudomonal antibiotics. References Davidi E, Paz A, Duchman H, Luntz M, Potasman I. Perichondritis of the auricle: analysis of 114 cases. Isr Med Assoc J. PMID: 21446231. Klug TE, Holm N, Greve T, Ovesen T.

Medical Schools 169

Medical Schools Immunity Immunization 169

Express Pharma

MAY 2, 2024

The 50:50 joint venture was established on January 28, 2011, for the sales and marketing of pharmaceutical products in India. Bayer Pharmaceuticals and Zydus Lifesciences announced the successful conclusion of their joint venture (JV) – Bayer Zydus Pharma. Bayer is now securing full ownership of the entity, as per pre-agreed JV terms.

Diabetes 105

Diabetes 105

Express Pharma

FEBRUARY 13, 2025

Dr. Hans Christoph Tanner, who has served on the board since 2011, will not seek re-election. DKSH announced changes to its board of directors ahead of its 92nd Annual General Meeting on March 27, 2025. The board has proposed Suwannee Ratthayabandith as a new member.

94

94

Pharmaceutical Business Review

FEBRUARY 19, 2025

As Calistoga Pharmaceuticals CEO, she led the company’s acquisition by Gilead in 2011. Currently, she serves on the boards of PMV Pharma, Slope.io, TREX Bio, Atara Bio, Recludix Pharmaceuticals, and OncoResponse. Later, she served as a partner and advisor in biopharma venture capital investing at New Enterprise Associates and Frazier.

52

52

Drug Patent Watch

DECEMBER 30, 2024

Pharmaceutical Regulations in Japan 2020. Retrieved from [link] Pharmaceuticals and Medical Devices Agency. Regulatory System on Generic Drugs in Japan. Retrieved from [link] Raflzadeh-Kabe, J. Japanese Pharmaceutical and Regulatory Environment. Journal of Clinical Pharmacology , 51(3), 531538.

Drug Development 52

Drug Development Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 52

ALiEM - Pharm Pearls

SEPTEMBER 13, 2024

Epub 2011 Dec 2. [link] globe-injury Ahmed Y, Schimel AM, Pathengay A, Colyer MH, Flynn HW Jr. Endophthalmitis following open-globe injuries. Eye (Lond). 2012 Feb;26(2):212-7. doi: 10.1038/eye.2011.313. PMID: 22134598; PMCID: PMC3272210.

Hospitals 161

Hospitals 161

pharmaphorum

OCTOBER 7, 2020

She published her findings in 2011, and later that year started collaborating with Doudna, a biochemistry specialist. In 2011, Emmanuelle Charpentier and Jennifer Doudna had no idea that their first meeting, in a café in Puerto Rico, would be life-changing. — The Nobel Prize (@NobelPrize) October 7, 2020.

105

105

The Guardian - Pharmaceutical Industry

MARCH 3, 2023

It was patented in 1993, eventually approved in 2011 and is now one of the leading treatments of advanced prostate cancer, branded as Zytiga. In the early 1990s, he and his colleagues at the Institute of Cancer Research in London designed the hormone therapy drug abiraterone acetate.

72

72

Pharmaceutical Commerce

NOVEMBER 13, 2023

Exparel was initially approved in 2011 for single-dose infiltration into a surgical site.

52

52

RX Note

JUNE 11, 2023

Mobile Application Mobile application for Medscape was released in 2009 and 2011 for iOS and Android system respectively. External Links Medscape - The First 5 Years, 2005 The most popular iPhone medical app, Medscape, is now on Android, 2011 Do not forget to download the database for offline usage.

52

52

pharmaphorum

MAY 19, 2022

He was found guilty in 2017 of securities fraud schemes involving two hedge funds that he ran, sending fake account statements in order to conceal huge losses, and also convicted of manipulating the price and trading volume of stock in Retrophin, another pharma company he founded in 2011. In January, Shkreli was ordered to repay $64.6

Drug Pricing 21

Drug Pricing 21

FDA Law Blog: Biosimilars

NOVEMBER 14, 2024

However, it’s fair to say that FDA’s food program has focused primarily on implementation of the many mandates in the Food Safety Modernization Act of 2011. More recently, the agency invested significant efforts in modernizing nutrition labeling requirements and implementing a sodium reduction initiative.

Labelling 64

Labelling Diabetes 64

Express Pharma

APRIL 6, 2023

The drug was granted accelerated approval in 2011 but ensuing studies did not verify the clinical benefit of the drug. Makena and its generic versions are the only approved treatments for reducing the risk of preterm birth, which affects one in every 10 babies in the US.

96

96

ALiEM - Pharm Pearls

NOVEMBER 27, 2023

Gynecol Surg 8, 129–134 (2011). Ultrasonographic findings in Fitz-Hugh-Curtis syndrome: a thickened or three-layer hepatic capsule. Yeungnam Univ J Med 35(1), 127-129 (2018). Theofanakis, C.P., Kyriakidis, A.V. Fitz-Hugh–Curtis syndrome. link] van Dongen PW. Diagnosis of Fitz-Hugh-Curtis syndrome by ultrasound. 1993 Jul;50(2):159-62.

161

161

Pharmaceutical Technology

JUNE 19, 2023

Novartis and Incyte Corp’s Jakafi was the first FDA-approved drug for the treatment of myelofibrosis in November 2011. First-in-line treatment for myelofibrosis currently involves treatment with Jakafi (ruxolitinib) in combination with other drugs such as danazol.

98

98

European Pharmaceutical Review

AUGUST 23, 2022

To achieve this objective, the regulation amends Directive 2011/24/EU on the application of patients’ rights in cross?border Directive 2011/24/EU had the merit of drawing attention to the need for an appropriate and centralised assessment of health technologies but failed to ensure effective harmonisation on the issue. Lorgelly PK.,

98

98

Pharmafile

AUGUST 24, 2022

The West African nation has successfully eliminated dracunculiasis (Guinea worm disease), elephantiasis (lymphatic filariasis), human African trypanosomiasis (sleeping sickness) and trachoma, in an effort spanning between 2011 and 2022. read more.

52

52

Pharmaceutical Technology

APRIL 7, 2023

Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous preterm birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth.

97

97

Express Pharma

SEPTEMBER 13, 2024

According to the 2011 Census, 8.6% Sickle Cell Disease, a genetic blood disorder, leads to severe health complications, including anemia and frequent pain episodes. The disease affects millions globally, with a significant impact in India and Africa.

105

105

pharmaphorum

JULY 28, 2021

He was also convicted of manipulating the price and trading volume of stock in Retrophin, another pharma company he founded in 2011. He was subsequently found guilty of securities fraud schemes involving two hedge funds that he ran, sending fake account statements in order to conceal huge losses. By Wutangcashew – I photographed it.

105

105

Pharmaceutical Technology

APRIL 7, 2023

Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of spontaneous preterm birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth.

95

95